259 related articles for article (PubMed ID: 22353833)
1. Overdiagnosis of breast cancer after 14 years of mammography screening.
Zahl PH; Mæhlen J
Tidsskr Nor Laegeforen; 2012 Feb; 132(4):414-7. PubMed ID: 22353833
[TBL] [Abstract][Full Text] [Related]
2. In situ breast cancer: incidence trend and organised screening programmes in Italy.
Barchielli A; Federico M; De Lisi V; Bucchi L; Ferretti S; Paci E; Ponti A; Buiatti E
Eur J Cancer; 2005 May; 41(7):1045-50. PubMed ID: 15862754
[TBL] [Abstract][Full Text] [Related]
3. Digital Mammography Screening: Does Age Influence the Detection Rates of Low-, Intermediate-, and High-Grade Ductal Carcinoma in Situ?
Weigel S; Hense HW; Heidrich J; Berkemeyer S; Heindel W; Heidinger O
Radiology; 2016 Mar; 278(3):707-13. PubMed ID: 26505802
[TBL] [Abstract][Full Text] [Related]
4. Incidence of and treatment for ductal carcinoma in situ of the breast.
Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Glass AG; Lacey JV; Carreon JD; Hoover RN
J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
[TBL] [Abstract][Full Text] [Related]
6. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
[TBL] [Abstract][Full Text] [Related]
7. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
[TBL] [Abstract][Full Text] [Related]
8. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma.
Ernster VL; Barclay J
J Natl Cancer Inst Monogr; 1997; (22):151-6. PubMed ID: 9709292
[TBL] [Abstract][Full Text] [Related]
9. Population-based mammography screening and breast cancer incidence in New South Wales, Australia.
Chiu C; Morrell S; Page A; Rickard M; Brassil A; Taylor R
Cancer Causes Control; 2006 Mar; 17(2):153-60. PubMed ID: 16425093
[TBL] [Abstract][Full Text] [Related]
10. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
Coldman A; Phillips N
CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
[TBL] [Abstract][Full Text] [Related]
11. Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use.
Farhat GN; Walker R; Buist DS; Onega T; Kerlikowske K
J Clin Oncol; 2010 Dec; 28(35):5140-6. PubMed ID: 21060026
[TBL] [Abstract][Full Text] [Related]
12. [Ductal carcinoma in situ of the breast].
Barth A; Köchli OR; Brenner RJ; Giuliano E; Castiglione M
Schweiz Med Wochenschr; 1995 Jan; 125(4):103-12. PubMed ID: 7878398
[TBL] [Abstract][Full Text] [Related]
13. Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983-2007.
Puig-Vives M; Pollan M; Rue M; Osca-Gelis G; Saez M; Izquierdo A; Marcos-Gragera R
Breast; 2012 Oct; 21(5):646-51. PubMed ID: 22340960
[TBL] [Abstract][Full Text] [Related]
14. Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands.
Ripping TM; Verbeek AL; Fracheboud J; de Koning HJ; van Ravesteyn NT; Broeders MJ
Int J Cancer; 2015 Aug; 137(4):921-9. PubMed ID: 25612892
[TBL] [Abstract][Full Text] [Related]
15. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
16. Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women.
Oseni TO; Zhang B; Coopey SB; Gadd MA; Hughes KS; Chang DC
J Am Coll Surg; 2019 Jun; 228(6):932-939. PubMed ID: 30772444
[TBL] [Abstract][Full Text] [Related]
17. Screening caused rising incidence rates of ductal carcinoma in situ of the breast.
van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
Breast Cancer Res Treat; 2009 May; 115(1):181-3. PubMed ID: 18516674
[TBL] [Abstract][Full Text] [Related]
18. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
Kalager M; Adami HO; Bretthauer M; Tamimi RM
Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
[TBL] [Abstract][Full Text] [Related]
19. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
20. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
Hendrick RE
Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
